Metraipolis › archive › dc_f703aa22da13

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU — Europe PMC PMID:42311903

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42311903
DOI
10.3389/fmed.2026.1839531
License (as archived)
solo-consultazione
Archived
2026-10-31T22:27:05.515Z
SHA-256 of the archived text
509365131da249b770380cea5f85436e37ca79089ce9421f835933651cdbc32c
Stable URL of this page
https://metraipolis.com/documento/dc_f703aa22da13

How to cite

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU — Europe PMC PMID:42311903 — Europe PMC (en), https://europepmc.org/article/MED/42311903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f703aa22da13 (Metraipolis archive dc_f703aa22da13, sha256 509365131da249b770380cea5f85436e37ca79089ce9421f835933651cdbc32c)
BibTeX
@misc{dcf703aa22da13,
  title = {Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU — Europe PMC PMID:42311903},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42311903},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f703aa22da13; sha256 509365131da249b770380cea5f85436e37ca79089ce9421f835933651cdbc32c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42311903. Agents can read the archived copy with the MCP tool read_document.